Sfoglia per Autore
Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with non-alcoholic fatty liver disease
2023-01-01 Rosso, Chiara; Caviglia, Gian Paolo; Birolo, Giovanni; Armandi, Angelo; Pennisi, Grazia; Pelusi, Serena; Younes, Ramy; Liguori, Antonio; Perez-Diaz-Del-Campo, Nuria; Nicolosi, Aurora; Govaere, Olivier; Castelnuovo, Gabriele; Olivero, Antonella; Abate, Maria Lorena; Ribaldone, Davide Giuseppe; Fariselli, Piero; Valenti, Luca; Miele, Luca; Petta, Salvatore; Romero-Gomez, Manuel; Anstee, Quentin M; Bugianesi, Elisabetta
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development
2023-01-01 Caviglia, Gian Paolo; Abate, Maria Lorena; Troshina, Giulia; Carucci, Patrizia; Rolle, Emanuela; Risso, Alessandra; Burlone, Michela Emma; Albè, Alice; Crevola, Martina; Musso, Emma Clara; Rosso, Chiara; Armandi, Angelo; Olivero, Antonella; Minisini, Rosalba; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Pirisi, Mario; Ciancio, Alessia; Gaia, Silvia
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification
2022-01-01 Olivero A.; Rosso C.; Ciancio A.; Abate M.L.; Nicolosi A.; Troshina G.; Armandi A.; Ribaldone D.G.; Saracco G.M.; Bugianesi E.; Rizzetto M.; Caviglia G.P.
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification.
2022-01-01 Olivero A, Rosso C, Ciancio A, Abate ML, Nicolosi A, Troshina G, Armandi A, Ribaldone DG, Saracco GM, Bugianesi E, Rizzetto M, Caviglia GP.
Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma
2022-01-01 Nicolosi, Aurora; Gaia, Silvia; Risso, Alessandra; Rosso, Chiara; Rolle, Emanuela; Abate, Maria L; Olivero, Antonella; Armandi, Angelo; Ribaldone, Davide G; Carucci, Patrizia; Fagoonee, Sharmila; Pellicano, Rinaldo; Saracco, Giorgio M; Bugianesi, Elisabetta; Caviglia, Gian P
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis
2022-01-01 Chiara Rosso, Cristina Demelas, Greta Agostini, Maria Lorena Abate, Marta Vernero, Gian Paolo Caviglia, Daphne D’Amato, Angelo Armandi, Marta Tapparo, Marta Guariglia, Giulia Troshina, Alessandro Massano, Antonella Olivero, Aurora Nicolosi, Antonella Zannetti, Rinaldo Pellicano, Alessia Ciancio, Giorgio Maria Saracco, Davide Giuseppe Ribaldone, Elisabetta Bugianesi, Sharmila Fagoonee
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease
2022-01-01 Caviglia G.P.; Nicolosi A.; Abate M.L.; Carucci P.; Rosso C.; Rolle E.; Armandi A.; Aneli S.; Olivero A.; Risso A.; Ribaldone D.G.; Fermer C.; Saracco G.M.; Gaia S.; Bugianesi E.
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease
2022-01-01 Armandi A.; Rosso C.; Nicolosi A.; Caviglia G.P.; Abate M.L.; Olivero A.; D'amato D.; Vernero M.; Gaggini M.; Saracco G.M.; Ribaldone D.G.; Leeming D.J.; Gastaldelli A.; Bugianesi E.
Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study
2021-01-01 Stelzl E.; Ciesek S.; Cornberg M.; Maasoumy B.; Heim A.; Chudy M.; Olivero A.; Miklau F.N.; Nickel A.; Reinhardt A.; Dietzsch M.; Kessler H.H.
The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease
2021-01-01 Caviglia G.P.; Martini S.; Ciancio A.; Niro G.A.; Olivero A.; Fontana R.; Tandoi F.; Rosso C.; Romagnoli R.; Saracco G.M.; Smedile A.; Rizzetto M.
Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
2021-01-01 Caviglia G.P.; Armandi A.; Rosso C.; Gaia S.; Aneli S.; Rolle E.; Abate M.L.; Olivero A.; Nicolosi A.; Guariglia M.; Ribaldone D.G.; Carucci P.; Saracco G.M.; Bugianesi E.
Hepatitis b virus reactivation upon immunosuppression: Is there a role for hepatitis b core-related antigen in patients with immune-escape mutants? a case report
2021-01-01 Caviglia G.P.; Zorzi A.; Rizzetto M.; Mirandola M.; Olivero A.; Carolo G.
The clinical role of serum epidermal growth factor receptor 3 in hepatitis c virus-infected patients with early hepatocellular carcinoma
2021-01-01 Caviglia G.P.; Abate M.L.; Rolle E.; Carucci P.; Armandi A.; Rosso C.; Olivero A.; Ribaldone D.G.; Tandoi F.; Saracco G.M.; Ciancio A.; Bugianesi E.; Gaia S.
Immunological and virological markers during pegylated interferon therapy in HDV chronic hepatitis: any predictor of response?
2020-01-01 Antonella Olivero, Gian Paolo Caviglia, Rossella Fontana, Maria Lorena Abate, Chiara Rosso, Giulia Troshina, Elisabetta Bugianesi, Giorgio Maria Saracco, Mario Rizzetto, Grazia Niro, Antonina Smedile, Alessia Ciancio
Performance of cytokeratin-18 apoptotic fragment for the identification of hepatic fibrosis and inflammation in patients with chronic viral hepatitis: a meta-analysis
2020-01-01 ROSSO, Chiara; CAVIGLIA, Gian P.; ARMANDI, Angelo; ABATE, Maria L.; OLIVERO, Antonella; RIBALDONE, Davide G.; PELLICANO, Rinaldo; SARACCO, Giorgio M.; BUGIANESI, Elisabetta
Application of serum cytokeratin-19 fragments (CYFRA 21-1) in predicting the prognosis of patients with hepatocellular carcinoma
2020-01-01 Gian Paolo Caviglia, Antonella Olivero, Michela Ciruolo, Patrizia Carucci, Emanuela Rolle, Chiara Rosso, Maria Lorena Abate, Alessandra Risso, Ramy Younes, Antonina Smedile, Giorgio Maria Saracco, Elisabetta Bugianesi, Silvia Gaia
Interplay between metabolic derangement, hepatic fibrogenesis and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease
2020-01-01 C. Rosso, R. Younes, D.J. Leening, R. Surabattula, G.P. Caviglia, M. Gaggini, A. Armandi, A. Olivero, M.L. Abate, A. Gastaldelli, D. Schuppan, E. Bugianesi
Insulin secretion is an independent predictor of hepatic ballooning in non-diabetic fatty liver disease.
2020-01-01 Ramy Younes, Chiara Rosso, Gian Paolo Caviglia, Angelo Armandi, Antonella Olivero, Maria Lorena Abate, Elisabetta Bugianesi
I nuovi marcatori dell'HBV hanno un reale ruolo clinico?
2020-01-01 Gian Paolo Caviglia; Antonella Olivero
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P
2020-01-01 Gian Paolo Caviglia, Chiara Rosso, Angelo Armandi, Melania Gaggini, Fabrizia Carli, Maria Lorena Abate, Antonella Olivero, Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Amalia Gastaldelli, Elisabetta Bugianesi
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with non-alcoholic fatty liver disease | 2023 | Rosso, Chiara; Caviglia, Gian Paolo; Birolo, Giovanni; Armandi, Angelo; Pennisi, Grazia; Pelusi, Serena; Younes, Ramy; Liguori, Antonio; Perez-Diaz-Del-Campo, Nuria; Nicolosi, Aurora; Govaere, Olivier; Castelnuovo, Gabriele; Olivero, Antonella; Abate, Maria Lorena; Ribaldone, Davide Giuseppe; Fariselli, Piero; Valenti, Luca; Miele, Luca; Petta, Salvatore; Romero-Gomez, Manuel; Anstee, Quentin M; Bugianesi, Elisabetta | |
| Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development | 2023 | Caviglia, Gian Paolo; Abate, Maria Lorena; Troshina, Giulia; Carucci, Patrizia; Rolle, Emanuela; Risso, Alessandra; Burlone, Michela Emma; Albè, Alice; Crevola, Martina; Musso, Emma Clara; Rosso, Chiara; Armandi, Angelo; Olivero, Antonella; Minisini, Rosalba; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Pirisi, Mario; Ciancio, Alessia; Gaia, Silvia | |
| Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification | 2022 | Olivero A.; Rosso C.; Ciancio A.; Abate M.L.; Nicolosi A.; Troshina G.; Armandi A.; Ribaldone D.G.; Saracco G.M.; Bugianesi E.; Rizzetto M.; Caviglia G.P. | |
| Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification. | 2022 | Olivero A, Rosso C, Ciancio A, Abate ML, Nicolosi A, Troshina G, Armandi A, Ribaldone DG, Saracco GM, Bugianesi E, Rizzetto M, Caviglia GP. | |
| Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma | 2022 | Nicolosi, Aurora; Gaia, Silvia; Risso, Alessandra; Rosso, Chiara; Rolle, Emanuela; Abate, Maria L; Olivero, Antonella; Armandi, Angelo; Ribaldone, Davide G; Carucci, Patrizia; Fagoonee, Sharmila; Pellicano, Rinaldo; Saracco, Giorgio M; Bugianesi, Elisabetta; Caviglia, Gian P | |
| Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis | 2022 | Chiara Rosso, Cristina Demelas, Greta Agostini, Maria Lorena Abate, Marta Vernero, Gian Paolo Caviglia, Daphne D’Amato, Angelo Armandi, Marta Tapparo, Marta Guariglia, Giulia Troshina, Alessandro Massano, Antonella Olivero, Aurora Nicolosi, Antonella Zannetti, Rinaldo Pellicano, Alessia Ciancio, Giorgio Maria Saracco, Davide Giuseppe Ribaldone, Elisabetta Bugianesi, Sharmila Fagoonee | |
| Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease | 2022 | Caviglia G.P.; Nicolosi A.; Abate M.L.; Carucci P.; Rosso C.; Rolle E.; Armandi A.; Aneli S.; Olivero A.; Risso A.; Ribaldone D.G.; Fermer C.; Saracco G.M.; Gaia S.; Bugianesi E. | |
| Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease | 2022 | Armandi A.; Rosso C.; Nicolosi A.; Caviglia G.P.; Abate M.L.; Olivero A.; D'amato D.; Vernero M.; Gaggini M.; Saracco G.M.; Ribaldone D.G.; Leeming D.J.; Gastaldelli A.; Bugianesi E. | |
| Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study | 2021 | Stelzl E.; Ciesek S.; Cornberg M.; Maasoumy B.; Heim A.; Chudy M.; Olivero A.; Miklau F.N.; Nickel A.; Reinhardt A.; Dietzsch M.; Kessler H.H. | |
| The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease | 2021 | Caviglia G.P.; Martini S.; Ciancio A.; Niro G.A.; Olivero A.; Fontana R.; Tandoi F.; Rosso C.; Romagnoli R.; Saracco G.M.; Smedile A.; Rizzetto M. | |
| Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease | 2021 | Caviglia G.P.; Armandi A.; Rosso C.; Gaia S.; Aneli S.; Rolle E.; Abate M.L.; Olivero A.; Nicolosi A.; Guariglia M.; Ribaldone D.G.; Carucci P.; Saracco G.M.; Bugianesi E. | |
| Hepatitis b virus reactivation upon immunosuppression: Is there a role for hepatitis b core-related antigen in patients with immune-escape mutants? a case report | 2021 | Caviglia G.P.; Zorzi A.; Rizzetto M.; Mirandola M.; Olivero A.; Carolo G. | |
| The clinical role of serum epidermal growth factor receptor 3 in hepatitis c virus-infected patients with early hepatocellular carcinoma | 2021 | Caviglia G.P.; Abate M.L.; Rolle E.; Carucci P.; Armandi A.; Rosso C.; Olivero A.; Ribaldone D.G.; Tandoi F.; Saracco G.M.; Ciancio A.; Bugianesi E.; Gaia S. | |
| Immunological and virological markers during pegylated interferon therapy in HDV chronic hepatitis: any predictor of response? | 2020 | Antonella Olivero, Gian Paolo Caviglia, Rossella Fontana, Maria Lorena Abate, Chiara Rosso, Giulia Troshina, Elisabetta Bugianesi, Giorgio Maria Saracco, Mario Rizzetto, Grazia Niro, Antonina Smedile, Alessia Ciancio | |
| Performance of cytokeratin-18 apoptotic fragment for the identification of hepatic fibrosis and inflammation in patients with chronic viral hepatitis: a meta-analysis | 2020 | ROSSO, Chiara; CAVIGLIA, Gian P.; ARMANDI, Angelo; ABATE, Maria L.; OLIVERO, Antonella; RIBALDONE, Davide G.; PELLICANO, Rinaldo; SARACCO, Giorgio M.; BUGIANESI, Elisabetta | |
| Application of serum cytokeratin-19 fragments (CYFRA 21-1) in predicting the prognosis of patients with hepatocellular carcinoma | 2020 | Gian Paolo Caviglia, Antonella Olivero, Michela Ciruolo, Patrizia Carucci, Emanuela Rolle, Chiara Rosso, Maria Lorena Abate, Alessandra Risso, Ramy Younes, Antonina Smedile, Giorgio Maria Saracco, Elisabetta Bugianesi, Silvia Gaia | |
| Interplay between metabolic derangement, hepatic fibrogenesis and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease | 2020 | C. Rosso, R. Younes, D.J. Leening, R. Surabattula, G.P. Caviglia, M. Gaggini, A. Armandi, A. Olivero, M.L. Abate, A. Gastaldelli, D. Schuppan, E. Bugianesi | |
| Insulin secretion is an independent predictor of hepatic ballooning in non-diabetic fatty liver disease. | 2020 | Ramy Younes, Chiara Rosso, Gian Paolo Caviglia, Angelo Armandi, Antonella Olivero, Maria Lorena Abate, Elisabetta Bugianesi | |
| I nuovi marcatori dell'HBV hanno un reale ruolo clinico? | 2020 | Gian Paolo Caviglia; Antonella Olivero | |
| Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P | 2020 | Gian Paolo Caviglia, Chiara Rosso, Angelo Armandi, Melania Gaggini, Fabrizia Carli, Maria Lorena Abate, Antonella Olivero, Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Amalia Gastaldelli, Elisabetta Bugianesi |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile